Company intelligence / Profile preview

OTV

Ownership: Private
Development stage: Other

Overview

OTV is an active global venture capital firm specializing in digital health investments. It has raised at least $170 million to invest in startups developing innovative healthcare technologies such as telemedicine solutions (TytoCare), home-based diagnostics (Lemonaid Health), genomics analysis tools (Emedgene), advanced microscopy for hematology diagnostics (Scopio Labs), and remote patient monitoring devices (Donisi Health). The fund has expanded its geographic focus to include Asia-Pacific with new offices in China alongside existing locations in Tel Aviv, New York, and Montreal.

Therapeutic areas: OtherHematology
Modalities: Digital health platformsAI-based diagnosticsRemote monitoring devicesGenomics analysis toolsDeviceDigital health platformAI software
Industry: Investors

Partnerships

Not specified at the fund level; individual portfolio companies have their own partnerships.

Beyond the preview

Go deeper on OTV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTV.

Explore the full profile